Globe Life Inc. $GL Shares Bought by Voya Investment Management LLC

Voya Investment Management LLC raised its holdings in Globe Life Inc. (NYSE:GL) by 105.2% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 68,291 shares of the company’s stock after acquiring an additional 35,014 shares during the quarter. Voya Investment Management LLC owned 0.08% of Globe Life worth $8,995,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of GL. Lazard Asset Management LLC lifted its holdings in Globe Life by 43.2% in the fourth quarter. Lazard Asset Management LLC now owns 10,999 shares of the company’s stock valued at $1,226,000 after acquiring an additional 3,317 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Globe Life by 4.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,784 shares of the company’s stock valued at $980,000 after buying an additional 385 shares in the last quarter. Nomura Holdings Inc. purchased a new position in shares of Globe Life in the fourth quarter valued at $558,000. Man Group plc increased its position in shares of Globe Life by 100.3% in the fourth quarter. Man Group plc now owns 75,728 shares of the company’s stock valued at $8,445,000 after buying an additional 37,922 shares in the last quarter. Finally, Quantinno Capital Management LP increased its position in shares of Globe Life by 99.6% in the fourth quarter. Quantinno Capital Management LP now owns 24,949 shares of the company’s stock valued at $2,782,000 after buying an additional 12,448 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Trading Down 1.0%

Globe Life stock opened at $141.04 on Wednesday. The stock has a market cap of $11.42 billion, a PE ratio of 11.27 and a beta of 0.56. The stock has a 50-day moving average price of $135.25 and a 200 day moving average price of $126.96. Globe Life Inc. has a 52 week low of $100.27 and a 52 week high of $144.00. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.43.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, topping analysts’ consensus estimates of $3.25 by $0.02. The firm had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.The firm’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the business posted $2.97 EPS. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. Equities research analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life’s dividend payout ratio (DPR) is presently 8.63%.

Insiders Place Their Bets

In other Globe Life news, CEO James Matthew Darden sold 33,270 shares of the firm’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $135.59, for a total value of $4,511,079.30. Following the sale, the chief executive officer directly owned 49,842 shares of the company’s stock, valued at approximately $6,758,076.78. This trade represents a 40.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 28,952 shares of the firm’s stock in a transaction dated Tuesday, July 29th. The stock was sold at an average price of $140.97, for a total value of $4,081,363.44. Following the completion of the sale, the chief financial officer directly owned 30,665 shares in the company, valued at approximately $4,322,845.05. The trade was a 48.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 84,722 shares of company stock valued at $11,733,793 in the last quarter. Corporate insiders own 1.97% of the company’s stock.

Analyst Ratings Changes

GL has been the subject of a number of research analyst reports. JPMorgan Chase & Co. raised their price target on Globe Life from $145.00 to $160.00 and gave the company an “overweight” rating in a research report on Tuesday, July 8th. Truist Financial initiated coverage on Globe Life in a research report on Tuesday, July 15th. They issued a “buy” rating and a $150.00 price target for the company. Morgan Stanley raised their price target on Globe Life from $166.00 to $171.00 and gave the company an “overweight” rating in a research report on Monday, August 18th. BMO Capital Markets restated a “market perform” rating and issued a $149.00 price target (up previously from $114.00) on shares of Globe Life in a research report on Wednesday, July 30th. Finally, Wells Fargo & Company raised their price target on Globe Life from $144.00 to $150.00 and gave the company an “overweight” rating in a research report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $152.45.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.